Head-to-head comparison of aptamer- and antibody-based proteomic platforms in human cerebrospinal fluid samples from a real-world memory clinic cohort
Puerta, R.; Cano, A.; Garcia-Gonzalez, P.; Garcia-Gutierrez, F.; Capdevila, M.; de Rojas, I.; Olive, C.; Blazquez-Folch, J.; Sotolongo-Grau, O.; Miguel, A.; Montrreal, L.; Martino, P.; Emon, A.; Orellana, A.; Sung, Y. J.; Frikke-Schmidt, R.; Marchant, N.; Lambert, J. C.; Rosende-Roca, M.; Alegret, M.; Fernandez, M. V.; Marquie, M.; Valero, S.; Tarrega, L.; Cruchaga, C.; Ramirez, A.; Boada, M.; Smets, B.; Cabrera-Socorro, A.; Ruiz, A.
Show abstract
High-throughput proteomic platforms have a crucial role in identifying novel Alzheimers disease (AD) biomarkers and pathways. In this study, we evaluated the reproducibility and reliability of aptamer-based (SomaScan(R) 7k) and antibody-based (Olink(R) Explore 3k) proteomic platforms in cerebrospinal fluid (CSF) samples from the Ace Alzheimer Center Barcelona real-world cohort. Intra- and interplatform reproducibility was evaluated through correlations between two independent SomaScan(R) assays analyzing the same samples and between SomaScan(R) and Olink(R) results. Our 12-category metric of reproducibility combining both correlation analyses identified 2,428 highly reproducible SomaScan CSF measures, with over 600 proteins well reproduced on another proteomic platform. The association analyses among AD clinical phenotypes revealed that the significant associations mainly involved reproducible proteins. The validation of reproducibility in these novel proteomics platforms, measured using this scarce biomaterial, is essential for accurate analysis and proper interpretation of innovative results. This classification metric could enhance confidence in multiplexed proteomic platforms and improve the design of future panels.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 95%
- Genoppi: an open-source software for robust and standardized integration of proteomic and genetic data 95%
- Imputation of label-free quantitative mass spectrometry-based proteomics data using self-supervised deep learning 95%
Similar papers in this journal
Similar papers in this journal
- The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy 93%
- Deep Proteome Profiling of Metabolic Dysfunction-Associated Steatotic Liver Disease 93%
- Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic and prognostic biosignatures for Parkinson’s Disease 93%
Similar papers in this journal
- Synapse protein signatures in cerebrospinal fluid and plasma predict cognitive maintenance versus decline in Alzheimers disease 94%
- Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations 92%
- HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.